Clinical trial
Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus
NCT00133367 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00133367 |
|---|---|
| Title | Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus |
| Official title | Phase II Study of Sequential Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus as Graft Versus Host Disease Prophylaxis |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Dana-Farber Cancer Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Multiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Disease, Myelogenous Leukemia, Lymphoblastic Leukemia |
| Intervention type | Drug |
| Interventions | Tacrolimus, Sirolimus, G-CSF, Antithymocyte globulin, Thymoglobulin, Fludarabine, Melphalan |
| Enrollment | 32 |
| Start date | Aug 1, 2005 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2011 |
| First posted | Aug 23, 2005 |
| Last update posted | Jul 25, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: